The global specialty generic drugs market, valued at USD 81.96 billion in 2024, is set for transformative growth, projected to reach USD 89.55 billion in 2025 and expand further to USD 202.66 billion by 2034, registering a CAGR of 9.5% between 2025 and 2034. This robust expansion reflects structural changes across regional pharmaceutical landscapes, driven by cost-containment measures,...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek